Using the Request for Quote (RFQ) form provided on this page, you can request competitive procurement options on part number NDC00591-0364-05 with rapid responses always offered by our staff. To ensure that you locate and procure exactly what you need with ease, we list parts with as much information as we can. For example, part number NDC00591-0364-05 It is listed as Clorazepate Dipotas. component manufactured by Danbury Pharmacal Inc, specifically under CAGE Code 62051. It is also accompanied by the NSN 6505012511850 for ease of organization, the first digits of the NSN indicating that the part belongs to FSC .
NSN Information for Part Number NDC00591-0364-05 with NSN 6505-01-251-1850, 6505012511850
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-251-1850 Item Description: Clorazepate Dipotas | 6505 | 012511850 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
Q | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00591-0364-05 | 2 | 2 | 5 |
Characteristics Data of NSN 6505-01-251-1850, 6505012511850
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS USP 500S BT |
FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |